港股期指迎新成员！恒生生物科技指数期货上市倒计时3天

Core Viewpoint - The launch of the Hang Seng Biotechnology Index futures on November 28 is expected to provide investors with new risk hedging tools and enhance liquidity in the biotechnology sector [1] Group 1: Index and Market Overview - The Hang Seng Biotechnology Index was launched by Hang Seng Indexes Company in 2019 to reflect the overall performance of the biotechnology sector in the Hong Kong stock market [1] - The index currently includes notable companies such as Innovent Biologics, BeiGene, WuXi Biologics, CanSino Biologics, and 3SBio, covering sub-sectors like CXO and innovative drugs [1] Group 2: Market Trends and Expectations - The introduction of the index futures is anticipated to attract foreign capital back to the biotechnology sector amid a global liquidity easing cycle initiated by the Federal Reserve's interest rate cuts [1] - The continuous inflow of southbound funds is expected to create a resonance effect, further boosting the biotechnology sector in the Hong Kong market [1]